Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancers|September 14, 2024
Resolution of Optimal Mitochondrial and Nuclear DNA Enrichment in Target-Panel Sequencing and Physiological Mitochondrial DNA Copy Number Estimation in Liver Cancer and Non-Liver Cancer SubjectsXue-Ying Lyu, Yu-Man Tsui, Ivan Ka-Kit Tam, et al.
Cancer Letters|June 14, 2019
Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancerDaniel Wai-Hung Ho, Yu-Man Tsui, Karen Man-Fong Sze, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stressHongyang Huang, Yu-Man Tsui, Daniel Wai-Hung Ho, et al.
Molecular Cancer|June 2, 2026
Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinomaFanhong Zeng, Jiaxin Guo, Zheng Zeng, et al.
Cell & Bioscience|December 20, 2021
Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1Vanilla Xin Zhang, Karen Man-Fong Sze, Lo-Kong Chan, et al.
Hepatology (Baltimore, Md.)|October 9, 2025
Targeting sterol O-acyltransferase 1 rewires fatty acid metabolism and uncovers immune vulnerability in hepatocellular carcinomaHuanhuan Ma, Vanilla Xin Zhang, Yu Man Tsui, et al.
Hepatology (Baltimore, Md.)|January 12, 2026
Repurposing resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppressionVanilla Xin Zhang, Tina Suoangbaji, Yu-Man Tsui, et al.
Hepatology (Baltimore, Md.)|May 9, 2025
GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCCTiffany Ching-Yun Yu, Luqing Zhao, Karen Man-Fong Sze, et al.
Nature Communications|March 22, 2021
RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2Xia Wang, Jin Wang, Yu-Man Tsui, et al.
Molecular Cancer|April 9, 2025
Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug responseFanhong Zeng, Qingyang Zhang, Yu-Man Tsui, et al.
Pageof 3